Deep vein thrombosis is a frequent manifestation of venous thromboembolism in which there is a blood clot blocking a deep vein.
Clinical findings are important to the diagnosis of deep vein thrombosis but are poor predictors of the presence or severity of thrombosis.
Pulmonary embolism is the blockage of the blood vessels in the lungs usually due to blood clots from the veins, especially veins in the legs and pelvis.
Dyspnea, pleuritic chest pain, syncope and tachypnea occur in most cases of pulmonary embolism.
Massive pulmonary embolism has the prime symptom of dyspnea and systemic arterial hypotension, that requires pressor support, is the predominant sign.
Drug Information

Indication: DVT & pulmonary embolism (PE). Prevention of stroke & systemic embolism in adult patients w/ non-valvu...

Indication: Thrombolytic treatment in acute MI (AMI): 90-min (accelerated) dose regimen for patients in whom treatment can...

Indication: Prevention of venous thromboembolic events (VTE) in patients undergoing major orthopaedic surgery of the lower...

aspirin + glycine

Indication: Transient ischaemic attacks, secondary prevention of MI. Prophylaxis against stroke, vascular occlusion & ...

Indication: Transient ischaemic attacks, secondary prevention of MI. Platelet aggregation inhibitor for prophylaxis agains...

Indication: AMI. Prevention of heart attack in certain high-risk patients; prevention of CVA after transient ischaemic att...

Indication: 10-mg tab Prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replace...

1  /  2
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Feb 2020

The consumption of processed meat or unprocessed red meat may be associated with a slightly elevated risk of incident cardiovascular disease (CVD)* and all-cause mortality, according to a US study.

Jairia Dela Cruz, 25 Nov 2019
Use of the PCSK9* inhibitor alirocumab in acute coronary syndrome (ACS) patients on a background of high-intensity statin treatment delivers reductions in total hospitalizations and death with corresponding gains in days alive and out of hospital (DAOH), according to the results of prespecified and posthoc analyses of the ODYSSEY OUTCOMES** trial presented at the American Heart Association (AHA) 2019 Scientific Sessions.
Roshini Claire Anthony, 06 Feb 2020

The presence of metabolic syndrome* appears to increase the risk of recurrent venous thromboembolism (VTE)** among patients with deep vein thrombosis (DVT), a recent study showed.

Jairia Dela Cruz, 13 Feb 2020
For regular drinkers with atrial fibrillation (AF), cutting down alcohol consumption confers beneficial effects on both the AF burden and risk of recurrence, according to a recent study.